Exagen Inc.(NasdaqGM:XGN) dropped from Russell 3000E Value Index
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.59 USD | +1.92% | -4.79% | -20.10% |
Mar. 18 | Exagen Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 18 | Earnings Flash (XGN) EXAGEN Reports Q4 Revenue $13.8M, vs. Street Est of $11.6M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.10% | 27.4M | |
+1.01% | 100B | |
+23.22% | 88.22B | |
+10.42% | 29.28B | |
-3.88% | 18.37B | |
-3.46% | 14.74B | |
+19.69% | 12.27B | |
+0.17% | 12.26B | |
+31.78% | 12.11B | |
-32.28% | 11.68B |
- Stock
- Equities
- Stock Exagen Inc. - Nasdaq
- News Exagen Inc.
- Exagen Inc.(NasdaqGM: XGN) dropped from Russell 3000E Value Index